- Home
- REPL vs SMWB Comparison
REPL vs SMWB Comparison
Compare REPL & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- SMWB
- Stock Information
- Founded
- REPL 2015
- SMWB 2007
- Country
- REPL United States
- SMWB Israel
- Employees
- REPL 479
- SMWB N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- SMWB Computer Software: Programming Data Processing
- Sector
- REPL Health Care
- SMWB Technology
- Exchange
- REPL Nasdaq
- SMWB Nasdaq
- Market Cap
- REPL 239.0M
- SMWB 695.0M
- IPO Year
- REPL 2018
- SMWB 2021
- Fundamental
- Price
- REPL $3.15
- SMWB $8.63
- Analyst Decision
- REPL Buy
- SMWB Strong Buy
- Analyst Count
- REPL 10
- SMWB 8
- Target Price
- REPL $8.25
- SMWB $15.75
- AVG Volume (30 Days)
- REPL 9.2M
- SMWB 500.6K
- Earning Date
- REPL 08-07-2025
- SMWB 08-05-2025
- Dividend Yield
- REPL N/A
- SMWB N/A
- EPS Growth
- REPL N/A
- SMWB N/A
- EPS
- REPL N/A
- SMWB N/A
- Revenue
- REPL N/A
- SMWB $258,017,999.00
- Revenue This Year
- REPL N/A
- SMWB $16.87
- Revenue Next Year
- REPL N/A
- SMWB $14.96
- P/E Ratio
- REPL N/A
- SMWB N/A
- Revenue Growth
- REPL N/A
- SMWB 15.06
- 52 Week Low
- REPL $2.68
- SMWB $5.71
- 52 Week High
- REPL $17.00
- SMWB $17.64
- Technical
- Relative Strength Index (RSI)
- REPL 24.82
- SMWB 54.99
- Support Level
- REPL $2.68
- SMWB $8.11
- Resistance Level
- REPL $3.85
- SMWB $9.26
- Average True Range (ATR)
- REPL 0.80
- SMWB 0.40
- MACD
- REPL -1.03
- SMWB 0.01
- Stochastic Oscillator
- REPL 4.45
- SMWB 45.22
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About SMWB Similarweb Ltd.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.